February 1, 2016
View Archives Issues
Death by prescription drugs is out of control.
The guideline builds on the “risk-based” statin treatment recommendations rather than the previous “treat-to-target” method of treating to a specific LDL cholesterol.
A new evidence review compares the weekly glucagon-like peptide-1 receptor agonists for the treatment of type 2 diabetes.
In this section: The FDA may soon recommend against using codeine for pain and cough in children underage children; vitamin D supplementation may not prevent elderly falls after all; agency approves insulin glargine for the treatment of diabetes; and mepolizumab for maintenance treatment of asthma when used with other asthma medications receives approval.